BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19242702)

  • 1. Seroprevalences of herpes simplex virus type 2 and Chlamydia trachomatis in Turkey.
    Maral I; Biri A; Korucuoğlu U; Bakar C; Cirak M; Ali Bumin M
    Arch Gynecol Obstet; 2009 Nov; 280(5):739-43. PubMed ID: 19242702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of Chlamydia trachomatis and herpes simplex virus type 1 or 2 in cervical samples in human papilloma virus (HPV)-positive and HPV-negative women.
    Finan RR; Musharrafieh U; Almawi WY
    Clin Microbiol Infect; 2006 Sep; 12(9):927-30. PubMed ID: 16882302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalences of herpes simplex virus type 2, five oncogenic human papillomaviruses, and Chlamydia trachomatis in Katowice, Poland.
    Görander S; Lagergård T; Romanik M; Viscidi RP; Martirosian G; Liljeqvist JA
    Clin Vaccine Immunol; 2008 Apr; 15(4):675-80. PubMed ID: 18287578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Seroprevalence of type 2 herpes simplex virus infection in 3 population groups of Mexico City].
    Conde-González CJ; Lazcano-Ponce E; Hernández-Girón C; Juárez-Figueroa L; Smith JS; Hernández-Avila M
    Salud Publica Mex; 2003; 45 Supp 5():S608-16. PubMed ID: 14974271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-infection of herpes simplex virus (HSV) with human immunodeficiency virus (HIV) in women with reproductive tract infections (RTI).
    Devi KM; Devi KhS; Singh NB; Singh NN; Singh ID
    J Commun Dis; 2008 Sep; 40(3):193-7. PubMed ID: 19245157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sero-prevalence of Herpes simplex virus type 2 (HSV-2) in Rakai district, Uganda.
    Emonyi IW; Gray RH; Zenilman J; Schmidt K; Wawer MJ; Sewankambo KN; Serwadda D; Kiwanuka N; Nalugoda F
    East Afr Med J; 2000 Aug; 77(8):428-30. PubMed ID: 12862067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 2 prevalence of epidemic proportions in rural Zimbabwean women: association with other sexually transmitted infections.
    Kjetland EF; Gwanzura L; Ndhlovu PD; Mduluza T; Gomo E; Mason PR; Midzi N; Friis H; Gundersen SG
    Arch Gynecol Obstet; 2005 Jun; 272(1):67-73. PubMed ID: 15647913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of herpes simplex virus type 1 and type 2 among the Indigenous population of Cape York, Far North Queensland, Australia.
    Brazzale AG; Russell DB; Cunningham AL; Taylor J; McBride WJ
    Sex Health; 2010 Dec; 7(4):453-9. PubMed ID: 21062586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence of Chlamydia trachomatis in Enugu, Nigeria.
    Ikeme AC; Ezegwui HU; Ikeako LC; Agbata I; Agbata E
    Niger J Clin Pract; 2011; 14(2):176-80. PubMed ID: 21860135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal change in HSV-2 seroreactivity: a cross-sectional Swedish population study.
    Jonsson MK; Levi M; Rudén U; Wahren B
    Scand J Infect Dis; 2006; 38(5):357-65. PubMed ID: 16709538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus type 2 and Chlamydia trachomatis in adenocarcinoma of the uterine cervix.
    Zereu M; Zettler CG; Cambruzzi E; Zelmanowicz A
    Gynecol Oncol; 2007 Apr; 105(1):172-5. PubMed ID: 17188342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence and determinants of herpes simplex type 2 infection in an STD clinic in Milan, Italy.
    Suligoi B; Calistri A; Cusini M; Palù G;
    J Med Virol; 2002 Jul; 67(3):345-8. PubMed ID: 12116025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance and outcome of herpes simplex virus type 2 antibody testing in patients attending an STD clinic--recognized and unrecognized infections.
    Löwhagen GB; Berntsson M; Bonde E; Tunbäck P; Krantz I
    Acta Derm Venereol; 2005; 85(3):248-52. PubMed ID: 16040412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genital ulcers and concomitant complaints in men attending a sexually transmitted infections clinic: implications for sexually transmitted infections management.
    O'Farrell N; Morison L; Moodley P; Pillay K; Vanmali T; Quigley M; Sturm AW
    Sex Transm Dis; 2008 Jun; 35(6):545-9. PubMed ID: 18356769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Herpes simplex virus type 1 and 2 in Switzerland].
    Laubereau B; Zwahlen M; Neuenschwander B; Heininger U; Schaad UB; Desgrandchamps D
    Schweiz Med Wochenschr; 2000 Feb; 130(5):143-50. PubMed ID: 10701231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania.
    Obasi A; Mosha F; Quigley M; Sekirassa Z; Gibbs T; Munguti K; Todd J; Grosskurth H; Mayaud P; Changalucha J; Brown D; Mabey D; Hayes R
    J Infect Dis; 1999 Jan; 179(1):16-24. PubMed ID: 9841817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence of herpes simplex virus-2 infection among women seeking medical care for signs and symptoms of vaginitis.
    Ross SE; Carter B; Lambert S
    Herpes; 2009 Jan; 15(3):46-50. PubMed ID: 19306602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiologic study of herpes simplex virus type 2 and cytomegalovirus among young adults in northern Jordan.
    Abuharfeil N; Meqdam MM
    New Microbiol; 2000 Jul; 23(3):235-9. PubMed ID: 10939038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serological profile of HSV-2 in patients attending STI clinic: evaluation of diagnostic utility of HSV-2 IgM detection.
    Choudhry S; Ramachandran VG; Das S; Bhattacharya SN; Mogha NS
    Indian J Pathol Microbiol; 2009; 52(3):353-6. PubMed ID: 19679959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A seroprevalence study of herpes virus type 2 infection in Israeli women: implications for routine screening.
    Isacsohn M; Bar On E; Yaeger Y; Smetana Z; Weiner D; Slater PE
    Isr J Med Sci; 1994; 30(5-6):379-83. PubMed ID: 8034487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.